Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in France

29 Sept 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Antibiotic Use and Resistance
Share to Urinary Tract Infections Management

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 34600019
DOI: 10.1016/j.jinf.2021.09.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreasing proportion of extended-spectrum beta-lactamase among E. coli infections during the COVID-19 pandemic in FrancePMID 34600019Read ↗

Current epidemiology, genetic evolution and clinical impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniaeSemantic proximity Read ↗

Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-lactamasesSemantic proximity Read ↗

Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamasesSemantic proximity Read ↗

Extended-Spectrum β-Lactamase Genes Traverse the Escherichia coli Populations of Intensive Care Unit Patients, Staff, and EnvironmentSemantic proximity Read ↗

High Prevalence of ST131 Subclades C2-H30Rx and C1-M27 Among Extended-Spectrum β-Lactamase-Producing Escherichia coli Causing Human Extraintestinal Infections in Patients From Two Hospitals of Spain and France During 2015.Semantic proximity Read ↗

Characterization of extended-spectrum β-lactamases and integrons in Escherichia coli isolates in a Spanish hospitalSemantic proximity Read ↗

CTX-M: changing the face of ESBLs in Europe.Semantic proximity Read ↗

Diversity of Escherichia coli strains producing extended-spectrum beta-lactamases in Spain: second nationwide study.Semantic proximity Read ↗

Prevalence and acquisition rate of extended spectrum beta lactamase producing gram-negative organisms (ESBL-GNO) in general medical patients in SwitzerlandSemantic proximity Read ↗

Prevalence of extended-spectrum beta-lactamases in group-1 beta-lactamase-producing isolates.Semantic proximity Read ↗

Extended-spectrum beta-lactamases: the role of inhibitors in therapy.Semantic proximity Read ↗

First report of the new emerging global clone ST1193 among clinical isolates of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from GermanySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.